LIFE CREATE, First Half Ordinary Profit Turns to Loss
352A LOIVE Co.,Ltd. 【J-GAAP】
Earnings ReportLOIVE Co.,Ltd. <352A> [TSE Growth] announced its financial results after the market closed on November 14th (15:31). The ordinary profit/loss (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2026 (April to September) turned into a loss of 0.01 billion yen (compared to a profit of 0.49 billion yen in the same period last year).
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the October to March period (second half) is expected to surge 3.2 times that of the same period last year, reaching 1.38 billion yen.
Kabutan News
Actual Performance and Financial Trends
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Progress Rate vs. First Half |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
5,252M | 44M | -12M | -17M | -1.4 | ー | Nov 14, 2025 | J-GAAP |
| YoY | － | － | － | － | － |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | 5,259M | 0M | -28M | -28M | -2.2 | 0 | May 15, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 5,252M | 44M | -12M | -17M | -1.4 | 0 | Nov 14, 2025 | J-GAAP |
| Revision Rate | -0.1% | － | +57.1% | +39.3% | +38.3% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
4,529M | 474M | 434M | 137M | 11.1 | 0 | May 15, 2025 | J-GAAP |
|
Guidance
Oct - Mar, 2025
|
7,063M | 1,376M | 1,381M | 931M | 72.2 | 0 | Nov 14, 2025 | J-GAAP |
| YoY | +56.0% | +190.3% | +218.2% | +579.6% | +549.4% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
8,492M | 1,004M | 930M | 500M | 40.6 | 0 | May 15, 2025 | J-GAAP |
|
Guidance
Mar, 2026
|
12,315M | 1,420M | 1,369M | 914M | 70.9 | 0 | May 15, 2025 | J-GAAP |
| YoY | +45.0% | +41.4% | +47.2% | +82.8% | +74.6% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Operating Profit Margin |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
2,194M | 340M | 327M | 231M | 18.7 | 15.5 | Apr 24, 2025 | J-GAAP |
|
|
2,335M | 134M | 107M | -94M | -7.6 | 5.7 | May 15, 2025 | J-GAAP |
|
|
2,417M | -93M | -128M | -91M | -7.3 | -3.8 | Aug 8, 2025 | J-GAAP |
|
|
2,835M | 137M | 116M | 74M | 6.0 | 4.8 | Nov 14, 2025 | J-GAAP |
| YoY | － | － | － | － | － |
Related Articles
-
Future Innovation Group, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 87%, Jul-Sep Ordinary Profit Increases by 5.8 times
Fri Nov 14, 2025 3:35 pm JST Earnings -
KLASS, 48% Increase in Ordinary Profit for The Current Fiscal Year
Fri Nov 14, 2025 3:35 pm JST Earnings -
Giken Holdings, First Half Ordinary Profit Increases by 51%, Jul-Sep Ordinary Profit Increases by 2.1 times
Fri Nov 14, 2025 3:35 pm JST Earnings -
BrightPath Biotherapeutics, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
Fri Nov 14, 2025 3:32 pm JST Earnings -
VELTRA, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 77%
Fri Nov 14, 2025 3:31 pm JST Earnings -
CRESTEC, Jul-Sep (1Q) Ordinary Profit Increases by 2.5 times
Fri Nov 14, 2025 3:31 pm JST Earnings -
eWeLL, Jul-Sep (3Q) Ordinary Profit Increases by 39%, Current Fiscal Year Dividend Revised Upward by 1 Yen
Fri Nov 14, 2025 3:31 pm JST Earnings -
Birdman, Jul-Sep (1Q) Net Income Loss Narrows
Fri Nov 14, 2025 3:30 pm JST Earnings -
Bleach Inc, Jul-Sep (1Q) Ordinary Profit Turns to Profit
Fri Nov 14, 2025 3:30 pm JST Earnings -
VLC HOLDINGS, First Half Net Income Turns to Loss, Jul-Sep Net Income Turns to Loss
Fri Nov 14, 2025 3:30 pm JST Earnings